RecruitingNot Applicable

Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan (ULYSSES)

Italy150 participantsStarted 2022-10-01

Plain-language summary

Conflicting evidence exist in the literature on the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic chest CT scan. The primary aim of this prospective, observational, multicenter study is to evaluate the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic CT scans. Secondary aims are related to the utility of bronchoscopy to detect occult malignancies, the source of the bleeding and the clinical features of the cohort

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥18 years old * Haemoptysis of unknown origin * Negative or non-diagnostic chest CT scan Exclusion Criteria: * Known bleeding lesions of the upper or lower respiratory airways * Chest CT scan diagnostic for hemoptysis etiology * Refusal to sign the informed consent * Refusal of bronchoscopy

What they're measuring

To evaluate the proportion of patients with haemoptysis and negative/non-diagnostic CT scans in whom bronchoscopy allows an aetiological (i.e., endoscopic and/or microbiological and/or anatomopathological) diagnosis

Timeframe: One year

Trial details

NCT IDNCT05634200

SponsorUniversity of Milan

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-01

Contact for this trial

Michele Mondoni, MD

0039 0281843025 michele.mondoni@asst-santipaolocarlo.it; michele.mondoni@unimi.it

View on ClinicalTrials.gov More Hemoptysis trials